INNSBRUCK, Austria, Feb. 27, 2013 /CNW/ - Austrian BIOCRATES Life Sciences AG, prime developer of cutting-edge metabolite metabolomics products, is about to launch the next edition of
its well-established research kit, AbsoluteIDQ® p150, for use with Thermo Scientific's TSQ Vantage Triple Stage
Quadrupole Mass Spectrometer.
BIOCRATES Life Sciences announces the launch of a new edition of its
well-established research kit, AbsoluteIDQ® p150. The kit, which has been available for use with AB Sciex and
Waters mass spectrometry systems, has now been designed to also run on
Thermo Scientific's TSQ Vantage Triple Stage Quadrupole Mass
Spectrometer, enabling even more research labs to harness the power of
targeted metabolite quantification based on a ready-to-use kit system.
Combined with a robust new ion source, second-generation ion optics and
hyperbolic quadrupoles, the Thermo Scientific TSQ Vantage delivers the
highest sensitivity with the lowest chemical noise.
AbsoluteIDQ p150 provides extensive metabolic information from a single targeted
assay, quantifying 158 metabolites using a FIA-MS/MS method. It
features the proprietary MetIDQ™ software, requires minute sample volumes (10 µL), and is suitable for
use with a wide range of biological samples, making it an excellent
choice for researchers looking for a cost-effective solution to measure
endogenous metabolites under quality-controlled conditions in their own
lab. The AbsoluteIDQ kits by BIOCRATES have been successfully applied in many different
areas, including diabetes, nephrology, sepsis, and CNS disorders, in
both clinical and pharmaceutical research.
BIOCRATES Life Sciences AG is a leading biotechnology company focused on
the development of metabolomics products as well as in vitro
diagnostics (IVDs) for early disease and progression detection in areas
such as nephrology, diabetes, oncology, and endocrinology. Our mass
spectrometry-based, standardized metabolomic kits and IVDs provide
unprecedented accuracy, precision, and multiplexing potential that will
help revolutionize the way personalized medicine is applied in R&D and
Please also visit us at http://www.biocrates.com.
SOURCE: BIOCRATES Life Sciences AG
For further information:
BIOCRATES Life Sciences AG